logo

iStock Rating

F
Details...
Enter Symbol click to research

GENTIUM SPA ADS (NASDAQ: GENT)

Sector: Medical

Current Price : $7.75

52 Week Low
$7.3752 Week High
$12.59
 

GENTIUM SP(NSDQ:GENT)
Gentium S.p.A is an Italian biopharmaceutical company focused on the research, discovery, and development of drugs to treat and prevent a variety of vascular diseases and conditions related to cancer and cancer treatments.
# Employees: 77
Address: ,,,ITA
Phone: 39 031 385111
Fax: 39 031 481784
Website: www.gentium.it
Email: scalabrese@gentium.it
Sector: Medical
Industry: MED-BIOMED/GENE
Executive Officers
Dr. Khalid Islam (C.E.O. and President)
Salvatore Calabrese (C.F.O. and Sr. Vice-President; Finance)
Carin Heringa (Sr. V.P.; Scientific Director)
Gigliola Bertoglio (Director)
Dr. Marco Brughera (Director,)
Dividend
Ex-Dividend Date: N/A
Annual Dividend: N/A
Current Dividend Yield: N/A
Dividend Paid (3 months): N/A
Indicated Dividend: N/A
Earnings
Last Earnings Date: 3/31/2013
Next Earnings Date(Expected): 9/12/2013
Mean EPS (Next Qtr): $0.02
Mean EPS (Year): $0.50
Mean Estimate(Long Term): ($0.01)
P/E Ratio(Based on EPS estimate): 15.840
Number of Estimates: 2
Shares Performance
Period gent Compare to S&P
YTD -29.51 % -38.21 %
4 Weeks -9.81 % -7.55 %
12 Weeks 3.36 % -1.08 %
Shares Information
Analyst Coverage: Y
Avg Volume: 11820
Shares Outstanding: 15M
Market Cap: $0.12B
52 Week High: $12.59
52 Week Low: $7.37
P/E Ratio: 42.100
PEG Ratio: -0.010
Split: On 1/1/1990 gent split by factor of 0.200
Earnings Performance
EPS Growth in Last Quarter: 20.00 %
EPS Growth in Last Year: 175.00 %
Sales Growth in Last Quarter: 9.59 %
Sales Growth in Last Quarter: 45.86 %
Financials
Qtr Book Value: $4.16
Cash Flow/Share: $41.99
Change in Payout Ratio: 0.000
Price/Sales: 2.970
Home | Login |Research | Earnings | Scans | Stock Charts | Chart School | Glossary |Submit Article | Join Blog Network | Advertise | Subscribe to RSS

Terms of Use | Privacy Policy | Copyright 2012 all rights reserved
Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia. Advertisement partners Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.